The battle to control malaria infection has been hampered by many factors, including emerging drug resistance. Now, two papers published in Nature have opened up the door to a wealth of compounds that can be explored in the development of novel antimalarials, in particular against Plasmodiumfalciparum, the parasite species that causes the most deaths.
展开▼
